Multi-centre, Open-label, First-in-man Study With Mucopad HA
NCT06276270
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Oral Mucositis
Interventions
DEVICE:
Mucopad HA
Sponsor
Contipro Pharma a.s.